Both oral administration in drinking water and intraperitoneal injection produced significant pressure increases, though direct gastric application showed effects within minutes
The mentioned DPP-4 inhibitors are orally active, rapidly absorbed, and suitable for once daily or twice daily administration, leading to a DPP-4 inhibition of 7090% over 24 h
Together, these effects contribute to a reduced risk of heart attack and stroke
GHK-Cu 5mg Testing (Body Protection Compound 157) is a synthetic pentadecapeptide derived from a protein found in gastric juice
Injection considerations Most research peptides are administered subcutaneously, meaning into the fat layer just beneath the skin
But whereas MT-I is a linear tridecapeptide, MT-II features a cyclic heptapeptide structure [3]